Clinical Trial Update: Nalbuphine as Adjuvant During Bilateral Suprazygomatic Maxillary Nerve Block for Pediatric Cleft Palate Repair

View source ↗

Summary

A clinical trial update indicates nalbuphine is being studied as an adjuvant to bilateral suprazygomatic maxillary nerve block for pain management in pediatric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cleft Palate

Drugs mentioned

• Nalbuphine (nalbuphine)

Snippet

Sponsor: Assiut University | Conditions: Complication Following Peripheral Nerve Block | Status: ACTIVE_NOT_RECRUITING